DENVER (GenomeWeb News) – As researchers get ready to wrap up the pilot phase of the Cancer Genome Atlas later this year, they're gearing up for the second phase of the project, which will likely involve sequencing roughly 20 to 25 tumor types in the next five years. Second-generation sequencing methods are playing an increasing role in this effort, attendees heard at the American Association for Cancer Research meeting here in Denver yesterday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.